ARMATA PHARMACEUTICALS, INC. Other Current Liabilities
ARMATA PHARMACEUTICALS, INC. (ARMP) had Other Current Liabilities of $195.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Other Liabilities, Current $195.00K.
- 2026-03-31: Other Liabilities, Current $372.00K.
- 2025-12-31: Other Liabilities, Current $487.00K.
- 2025-09-30: Other Liabilities, Current $503.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $195.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $372.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $487.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $503.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $137.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $337.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $529.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $513.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $124.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $322.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $523.00K 10-K · filed 2025-03-21 |
| 2017-09-30 | $20.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $81.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $161.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $185.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |